Facetten
Zugriff
Einrichtung
Medientyp
- Text 83
Karte
Erscheinungsjahr
Autor/in
- Reich, Kristian
- Augustin, Matthias 35
- Mrowietz, Ulrich 18
- Radtke, Marc Alexander 8
- Thaçi, Diamant 8
- alle zeigen
Sprache
83 Einträge gefunden
-
Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial
- Reich, Kristian
- Kristensen, Lars Erik
- Smith, Saxon D
- Rich, Phoebe
- Sapin, Christophe
- Leage, Soyi Liu
- McKenzie, Robert
-
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis
- Reich, Kristian
- Conrad, Curdin
- Kristensen, Lars Erik
- Smith, Saxon D
- Puig, Luis
- Rich, Phoebe
- Sapin, Christophe
-
Maintenance of response in moderate-to-severe psoriasis after withdrawal of the interleukin (IL)-17A and IL-17F nanobody sonelokimab: is there a role for IL-17F in disease reoccurrence?
2022 - Forschungsinformationssystem des UKE - frei zugänglich -
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
- Gordon, Kenneth B
- Foley, Peter
- Krueger, James G
- Pinter, Andreas
- Reich, Kristian
- Vender, Ronald
- Vanvoorden, Veerle
-
Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis
- Fahrbach, Kyle
- Sarri, Grammati
- Phillippo, David M
- Neupane, Binod
- Martel, Samantha E
- Kiri, Sandeep
- Reich, Kristian
-
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)
- Eyerich, Kilian
- Weisenseel, Peter
- Pinter, Andreas
- Schäkel, Knut
- Asadullah, Khusru
- Wegner, Sven
- Muñoz-Elias, Ernesto J
-
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study
- Mrowietz, Ulrich
- Burden, A David
- Pinter, Andreas
- Reich, Kristian
- Schäkel, Knut
- Baum, Patrick
- Datsenko, Yakov
-
Which PASI Outcome Is Most Relevant to the Patients in Real-World Care?
- Kirsten, Natalia
- Rustenbach, Stephan
- von Kiedrowski, Ralph
- Sorbe, Christina
- Reich, Kristian
- Augustin, Matthias
-
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
- Reich, Kristian
- Papp, Kim A
- Blauvelt, Andrew
- Langley, Richard G
- Armstrong, April
- Warren, Richard B
- Gordon, Kenneth B
-
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 1: Therapieziele und Therapieempfehlungen
- Nast, Alexander
- Altenburg, Andreas
- Augustin, Matthias
- Boehncke, Wolf-Henning
- Härle, Peter
- Klaus, Joachim
- Koza, Joachim
-
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
- Reich, Kristian
- Teixeira, Henrique D
- de Bruin-Weller, Marjolein
- Bieber, Thomas
- Soong, Weily
- Kabashima, Kenji
- Werfel, Thomas
-
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials
- Silverberg, Jonathan I
- Simpson, Eric L
- Wollenberg, Andreas
- Bissonnette, Robert
- Kabashima, Kenji
- DeLozier, Amy M
- Sun, Luna
-
Quality of psoriasis care in Germany - results from the nationwide health care studies PsoHealth 2004-2017
- Langenbruch, Anna
- Mohr, Nicole
- Kirsten, Nathalie
- Reich, Kristian
- von Kiedrowski, Ralph
- Strömer, Klaus
- Mrowietz, Ulrich
-
Mouse models of atopic dermatitis: a critical reappraisal
2021 - Forschungsinformationssystem des UKE -
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität
- Nast, Alexander
- Altenburg, Andreas
- Augustin, Matthias
- Boehncke, Wolf-Henning
- Härle, Peter
- Klaus, Joachim
- Koza, Joachim
-
Bimekizumab versus Secukinumab in Plaque Psoriasis
- Reich, Kristian
- Warren, Richard B
- Lebwohl, Mark
- Gooderham, Melinda
- Strober, Bruce
- Langley, Richard G
- Paul, Carle
-
IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
2021 - Forschungsinformationssystem des UKE -
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
- Mehta, Heena
- Mashiko, Shunya
- Angsana, Julianty
- Rubio, Manuel
- Hsieh, Ya-Ching M
- Maari, Catherine
- Reich, Kristian
-
-
Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care
- da Silva, Neuza Maria Bernardino
- Augustin, Matthias
- Langenbruch, Anna Katharina
- Mrowietz, Ulrich
- Reich, Kristian
- Thaçi, Diamant
- Boehncke, Wolf-Henning